MedTrace Logo

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

NCT07329673 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-05-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate QbMobile's ability to collect objective data to identify specific symptom profiles in differential diagnoses (ASD, MDD, Bipolar Disorder and Anxiety Disorder) that are common with ADHD.

Conditions

  • Bi-Polar Disorder
  • Autism Spectrum Disorder (ASD)
  • Major Depression Disorders
  • Separation Anxiety Disorder
  • Social Anxiety Disorder
  • Generalized Anxiety Disorder (GAD)

Interventions

DEVICE

Digital software application for cognitive performance and activity measurement (QbMobile, investigational device)

Participants will complete two non-invasive, 10-minute digital tests using the QbMobile Investigational Device-one at the clinic and one at home the following day. The tests objectively measure cognitive performance and activity levels and will not influence clinical diagnosis or treatment in this study.

Sponsors & Collaborators

  • Qbtech AB

    lead INDUSTRY

Eligibility

Min Age
6 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07329673 on ClinicalTrials.gov